In recent years, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) analogues, such as semaglutide, tirzepatide, and others, have become a real phenomenon not only in medicine, but also in economics, society, and popular culture
A1C went down 1.7% to 2.0% with an average weight loss of 32.3 kg (71.2 lbs) for the highest dose over 68 weeks
GLP-1 drugs seem to fight addiction by reducing the hormone dopamine in a brain system involved in reward, motivation and stress a system "that is co-opted or hijacked, if you will, by addiction," Al-Aly says
Your provider will determine your starting point, adjust doses based on your response, and guide you to an effective maintenance dose
The researchers maintained regular contact with participants through weekly phone calls and monthly meetings, providing support and monitoring compliance